Japan's Takeda Pharma mulls sale of $3b emerging-market assets

Japan's Takeda Pharma mulls sale of $3b emerging-market assets

Photo: Bloomberg

Manuel Baigorri

22 January, 2019

Shire Plc Takeda Pharmaceutical Co.

Printed by Unregistered user on Wed, 17 Dec 2025 17:16:49 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Read more from World

Diageo sells 65% stake in East African Breweries to Asahi for $2.3b

Coursera to buy Udemy to create $2.5b firm to target AI training